Public Policy
Clinical Pharmacology & Therapeutics (2008) 83, 3, 498–500.doi:10.1038/sj.clpt.6100256
Benefit/Risk Ratio of Statins in Primary Prevention
MM Reidenberg1
1Departments of Pharmacology, Medicine, and Public Health, Weill Cornell Medical College, New York, New York, USA
Correspondence: MM Reidenberg, mmreid@med.cornell.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
